Date | Title | Presentation Obligator |
---|---|---|
2025/07/09 | Ex-Rights(유상증자) | KOSDAQ STOCK MKT. |
2025/07/09 | [Revised]Decision on Paid-in Capital Increase(주주배정후 실권주 일반공모) | |
2025/07/09 | Initial (Tentative) Issue Price of Rights Offering | |
2025/06/25 | Non-Designation as Violator of Disclosure Regulations(지정유예) | KOSDAQ STOCK MKT. |
2025/06/10 | Organization of Investor Relations Event | |
2025/06/10 | Decision on Paid-in Capital Increase(주주배정후 실권주 일반공모) | |
2025/06/05 | Prior Notice of Designation as Violator of Disclosure Regulations(공시번복) | KOSDAQ STOCK MKT. |
2025/05/26 | Material Management Information related to Judgment of Investment(Application for IND Approval)(중등도 및 중증 ARDS 환자대상 hUCB-MSC3-XT Inj.의 호주 제1상 임상시험계획 신청) | |
2025/05/09 | [Revised]Decision on Merger(소규모합병-철회) | |
2025/05/02 | Material Management Information related to Judgment of Investment(Application for Approval for IND Modification)(퓨어스템-에이디주(FURESTEM-AD Inj.)의 반복투여 제1/2a 임상시험계획 변경승인신청) |